Luigino Calzetta Selected Research

reslizumab

7/2021	Oral Corticosteroids Dependence and Biologic Drugs in Severe Asthma: Myths or Facts? A Systematic Review of Real-World Evidence.
11/2019	Age does not affect the efficacy of anti-IL-5/IL-5R in severe asthmatics.
1/2019	Monoclonal antibodies for severe asthma: Pharmacokinetic profiles.
2/2018	Pharmacokinetic/pharmacodynamic profile of reslizumab in asthma.
9/2017	Pharmacokinetic/pharmacodynamic drug evaluation of benralizumab for the treatment of asthma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luigino Calzetta Research Topics

Disease

101	Chronic Obstructive Pulmonary Disease (COPD) 06/2022 - 04/2010
65	Asthma (Bronchial Asthma) 08/2022 - 04/2010
18	Inflammation (Inflammations) 07/2022 - 04/2010
7	Pneumonia (Pneumonitis) 01/2022 - 05/2017
6	COVID-19 01/2022 - 01/2020
6	Respiratory Hypersensitivity 11/2021 - 03/2012
4	Chronic Bronchitis 06/2022 - 09/2015
4	Lung Diseases (Lung Disease) 02/2022 - 03/2012
4	Heart Failure 01/2020 - 09/2010
3	Airway Obstruction (Choking) 01/2022 - 10/2017
3	Chronic Cough 01/2022 - 07/2016
3	Dyspnea (Shortness of Breath) 01/2022 - 12/2013
3	Hypersensitivity (Allergy) 10/2017 - 01/2016
2	Diabetes Mellitus 02/2022 - 12/2014
2	Headache (Headaches) 01/2018 - 08/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 05/2017 - 09/2010
2	Bronchial Spasm 01/2016 - 06/2013
2	Hypoxia (Hypoxemia) 12/2013 - 09/2010
1	Cough 06/2022
1	Eosinophilia 01/2022

Drug/Important Bio-Agent (IBA)

39	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2022 - 05/2011
22	Muscarinic AntagonistsIBA 07/2022 - 05/2011
21	Bronchodilator Agents (Bronchodilators)IBA 06/2022 - 09/2011
17	Pharmaceutical PreparationsIBA 11/2020 - 09/2010
10	Cholinergic Agents (Cholinergics)IBA 06/2022 - 08/2015
10	Tiotropium Bromide (Spiriva)FDA Link 06/2022 - 09/2010
8	Biological ProductsIBA 07/2022 - 07/2016
8	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 06/2022 - 12/2014
8	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2022 - 04/2015
7	indacaterolIBA 01/2022 - 07/2012
7	Monoclonal AntibodiesIBA 09/2021 - 04/2015
7	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2020 - 05/2011
6	Biomarkers (Surrogate Marker)IBA 06/2022 - 10/2016
6	benralizumabIBA 01/2022 - 09/2017
6	Formoterol Fumarate (Oxis)FDA Link 04/2021 - 10/2015
6	Albuterol (Salbutamol)FDA LinkGeneric 01/2021 - 04/2011
6	Expectorants (Mucolytics)IBA 11/2020 - 01/2017
6	Acetylcysteine (Siran)FDA LinkGeneric 05/2019 - 09/2015
5	reslizumabIBA 07/2021 - 09/2017
5	mepolizumabIBA 07/2021 - 09/2017
5	doxofyllineIBA 01/2020 - 01/2018
4	vilanterolIBA 03/2022 - 07/2012
4	fluticasone furoate FDA Link 03/2022 - 07/2016
4	SteroidsIBA 02/2022 - 08/2018
4	Interleukin-5 (Interleukin 5)IBA 09/2021 - 01/2018
4	Beclomethasone (Beclometasone)FDA Link 04/2021 - 12/2018
4	CytokinesIBA 04/2020 - 04/2010
4	ensifentrineIBA 10/2019 - 11/2013
4	Theophylline (Theon)FDA LinkGeneric 01/2019 - 01/2018
4	AllergensIBA 01/2018 - 01/2016
4	Phosphodiesterase 4 InhibitorsIBA 08/2016 - 11/2013
3	Acetylcholine (Acetylcholine Chloride)FDA Link 06/2022 - 01/2021
3	GSK573719IBA 03/2022 - 12/2014
3	LipopolysaccharidesIBA 01/2022 - 01/2017
3	Omalizumab (Xolair)FDA Link 09/2021 - 01/2019
3	dupilumabIBA 09/2021 - 01/2019
3	GlucocorticoidsIBA 12/2020 - 01/2014
3	erdosteineIBA 11/2020 - 01/2018
3	Therapeutic UsesIBA 01/2020 - 09/2016
3	tiotropium-olodaterolIBA 01/2020 - 04/2016
3	AntioxidantsIBA 05/2019 - 01/2017
3	RoflumilastIBA 01/2018 - 07/2016
3	Cholinergic Antagonists (Anticholinergics)IBA 01/2016 - 09/2010
3	Oxygen (Dioxygen)IBA 12/2013 - 09/2010
2	Cholinergic ReceptorsIBA 06/2022 - 01/2021
2	Capsaicin (Zostrix)FDA Link 01/2022 - 12/2011
2	Mometasone Furoate (Nasonex)FDA LinkGeneric 01/2022 - 10/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2019
2	tezepelumabIBA 09/2021 - 04/2020
2	Humanized Monoclonal AntibodiesIBA 09/2021 - 09/2017
2	Interleukin-13IBA 09/2021 - 04/2020
2	Immunoglobulin E (IgE)IBA 09/2021 - 10/2017
2	Budesonide (Pulmicort)FDA LinkGeneric 04/2021 - 01/2016
2	Messenger RNA (mRNA)IBA 03/2021 - 07/2015
2	GoldIBA 07/2020 - 08/2015
2	Proteins (Proteins, Gene)FDA Link 04/2020 - 01/2018
2	XanthineIBA 06/2018 - 01/2018
2	Heparin (Liquaemin)FDA LinkGeneric 01/2018 - 01/2018
2	ChemokinesIBA 01/2018 - 09/2016
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2017 - 06/2012
2	Angiotensin II Type 1 Receptor BlockersIBA 05/2017 - 06/2012
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2017 - 06/2012
2	SmokeIBA 05/2017 - 09/2012
2	Oxidants (Oxidizing Agents)IBA 01/2017 - 01/2016
2	Glucose (Dextrose)FDA LinkGeneric 12/2016 - 10/2012
2	Adenosine Monophosphate (AMP)IBA 07/2016 - 03/2012
2	olodaterolIBA 04/2016 - 07/2012
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	mesoglycanIBA 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	IridiumIBA 01/2022
1	ArgonIBA 01/2022

Therapy/Procedure

70	Therapeutics 08/2022 - 09/2010
11	Nebulizers and Vaporizers (Inhaler) 08/2022 - 09/2011
3	Biological Therapy 07/2022 - 01/2018
3	Precision Medicine 09/2021 - 01/2017
2	Drug Therapy (Chemotherapy) 07/2022 - 01/2019
2	Duration of Therapy 12/2020 - 01/2017
1	Secondary Prevention 02/2022
1	Telerehabilitation 01/2022